Barclays analyst Julian Mitchell downgraded Emerson (NYSE: EMR) from Overweight to Equalweight with a price target of $71.00 (from $85.00).The ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE